D. Garceau

Tramiprosate in mild-to-moderate Alzheimer’s disease – a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)

Paul Aisen, Serge Gauthier, Steven H. Ferris et al. · Archives of Medical Science · 2011 · 277 citations · Full text

Eprodisate for the Treatment of Renal Disease in AA Amyloidosis

Laura M. Dember, Philip N. Hawkins, Bouke P. C. Hazenberg et al. · New England Journal of Medicine · 2007 · 271 citations

A Phase II study targeting amyloid-β with 3APS in mild-to-moderate Alzheimer disease

Paul Aisen, Daniel Saumier, Richard Briand et al. · Neurology · 2006 · 199 citations

Effect of tramiprosate in patients with mild-to-moderate alzheimer's disease: Exploratory analyses of the MRI sub-group of the alphase study

Serge Gauthier, Paul Aisen, Steven H. Ferris et al. · The journal of nutrition health & aging · 2009 · 133 citations · Full text

Alphase Study, Alzheimer's Disease, Dementia +9

BLU-5937: A selective P2X3 antagonist with potent anti-tussive effect and no taste alteration

D. Garceau, Nathalie Chauret · Pulmonary Pharmacology & Therapeutics · 2019 · 96 citations

Medicine, Selective P2x3 Antagonist, Pharmacological Agent +6